← Back to headlines
Novo Nordisk to Invest €430 Million in Athlone Plant for Wegovy Production
Novo Nordisk, the company behind the injectable weight-loss drug Wegovy, plans to invest €430 million in its Athlone plant to enhance the production of Wegovy in pill form.
2 Mar, 14:34 — 2 Mar, 14:34
Sources
Showing 1 of 1 sources
Related Stories
US and Iran Resume Direct Military Strikes as Oil Prices Surge
19m ago
US Treasury Secretary Urges Bank of Japan to Maintain Sound Monetary Policy Amid Yen Volatility
2h ago
Apple Sets Executive Pay for New CEO John Ternus and Chair Tim Cook
2h ago
BOJ to debate rate rise, inflation much closer to 2% target: governor
2h ago